Cart (0 Items)
Your cart is currently empty.
View ProductsBrand | ProteoGenix |
---|---|
Product type | Elisa assay kits |
Size | 1 kit |
Product name | Monkeypox Virus (MPXV) A29L Antigen ELISA Kit |
---|---|
Delivery condition | Blue ice (+4°) |
Storage condition | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
Brand | ProteoGenix |
Size | 1 kit |
Reference | KPTX106 |
Note | For research use only. |
Sample type | Plasma, Serum |
Immunogen | A29L |
Monkeypox virus (MPXV) is a zoonotic virus that belongs to the family Poxviridae and is closely related to the human smallpox virus. It is primarily found in Central and West Africa and can cause a severe and potentially fatal illness in humans. The A29L antigen is a key protein found on the surface of the MPXV and is an important target for both diagnostic and therapeutic purposes. In this article, we will provide a comprehensive description of the structure, activity, and application of the Monkeypox Virus A29L Antigen ELISA Kit.
The A29L antigen is a glycoprotein that is approximately 25 kDa in size. It is composed of 226 amino acids and is highly conserved among different strains of MPXV. The protein has a transmembrane domain and is anchored to the viral envelope. The antigen contains several important functional domains, including a signal peptide, a receptor-binding domain, and a conserved region that is involved in virus-host interactions.
The A29L antigen plays a crucial role in the pathogenesis of MPXV. It is involved in the attachment and entry of the virus into host cells by binding to cellular receptors. The receptor-binding domain of the antigen has been identified as the site of interaction with the host cell, and mutations in this domain have been shown to affect the virus’s ability to infect cells. Additionally, the A29L antigen is also involved in the fusion of the viral envelope with the host cell membrane, which is necessary for the virus to enter the host cell.
The Monkeypox Virus A29L Antigen ELISA Kit is a diagnostic tool that is used for the detection of MPXV infection in humans and animals. The kit utilizes an enzyme-linked immunosorbent assay (ELISA) technique to detect the presence of antibodies against the A29L antigen in a patient’s serum or plasma. The presence of these antibodies indicates a past or current infection with MPXV.
The A29L Antigen ELISA Kit has been shown to have high sensitivity and specificity for the detection of MPXV infection. It can detect both IgM and IgG antibodies, which are produced at different stages of the infection, allowing for early and accurate diagnosis. This is particularly important in areas where MPXV is endemic, as early detection can help contain the spread of the virus and prevent outbreaks.
In addition to its diagnostic application, the A29L Antigen ELISA Kit has also been used for research purposes to study the dynamics of MPXV infection and to evaluate the effectiveness of potential therapeutics. The kit can be used to measure the levels of A29L antigen-specific antibodies in response to different treatments, providing valuable insights into the immune response to MPXV infection.
The A29L antigen has also been identified as a potential therapeutic target for the development of antiviral drugs to treat MPXV infection. By targeting the receptor-binding domain of the antigen, it may be possible to prevent the virus from entering and infecting host cells. This approach has shown promising results in animal studies, and further research is being conducted to develop effective treatments for MPXV infection.
In summary, the A29L antigen is an important protein found on the surface of the Monkeypox virus and is involved in its attachment and entry into host cells. The Monkeypox Virus A29L Antigen ELISA Kit is a valuable tool for the diagnosis of MPXV infection and has also been used for research and therapeutic purposes. Further studies on the structure and function of the A29L antigen may lead to the development of effective treatments for this potentially fatal disease.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.